149 related articles for article (PubMed ID: 35082775)
1. Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy.
Shang B; Cao C; Jiang W; Shi H; Bi X; Cui C; Shou J; Zheng S; Zhang J; Zhou A; Li C; Ma J
Front Immunol; 2021; 12():720359. PubMed ID: 35082775
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
Calaway AC; Tachibana I; Masterson TA; Foster RS; Einhorn LH; Cary C
Urology; 2019 May; 127():74-79. PubMed ID: 30807775
[TBL] [Abstract][Full Text] [Related]
4. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
[TBL] [Abstract][Full Text] [Related]
5. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.
Silberstein JL; Bazzi WM; Vertosick E; Carver BS; Bosl GJ; Feldman DR; Bajorin DF; Motzer RJ; Al-Ahmadie H; Reuter VE; Sheinfeld J
J Urol; 2014 Aug; 192(2):415-9. PubMed ID: 24518791
[TBL] [Abstract][Full Text] [Related]
7. Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
Fresneau B; Orbach D; Faure-Conter C; Verité C; Castex MP; Kalfa N; Martelli H; Patte C
Pediatr Blood Cancer; 2015 Dec; 62(12):2114-9. PubMed ID: 26206391
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
[TBL] [Abstract][Full Text] [Related]
9. Current treatment of testicular sex cord-stromal tumors: critical review.
Acar C; Gurocak S; Sozen S
Urology; 2009 Jun; 73(6):1165-71. PubMed ID: 19362328
[TBL] [Abstract][Full Text] [Related]
10. Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives.
Borghesi M; Brunocilla E; Schiavina R; Gentile G; Dababneh H; Della Mora L; del Prete C; Franceschelli A; Colombo F; Martorana G
Actas Urol Esp; 2015; 39(1):57-62. PubMed ID: 24775811
[TBL] [Abstract][Full Text] [Related]
11. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
12. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
15. Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.
Laclergerie F; Mouillet G; Frontczak A; Balssa L; Eschwege P; Saussine C; Larré S; Cormier L; Vuillemin AT; Kleinclauss F
World J Urol; 2018 Mar; 36(3):427-433. PubMed ID: 29230496
[TBL] [Abstract][Full Text] [Related]
16. Malignant testicular unclassified sex cord stromal tumor: a case report.
Morinaga S; Aoki S; Tsuzuki T; Kanematsu K; Kawai N; Sato S; Nakamizu K; Goto K; Niwa M; Nomura I; Sawada T; Futamachi R; Morita F; Yamada Y
J Med Case Rep; 2022 Nov; 16(1):406. PubMed ID: 36335378
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
18. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
Heidenreich A; Paffenholz P; Nestler T; Pfister D
Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
[TBL] [Abstract][Full Text] [Related]
19. Malignant undifferentiated sex cord-stromal testis tumor with brain metastasis: case report.
Kumaravelu PG; Vella S; Pontes JE; Heath EI
Urol Oncol; 2008; 26(1):53-5. PubMed ID: 18190831
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
